公司概覽
業務類別 Specialty Chemicals
業務概覽 Westlake is a forward-integrated commodity chemicals firm based in Houston. It began as a single low-density polyethylene plant and expanded its capabilities to include ethylene, vinyl chloride monomers, and polyvinyl chloride over the next two decades. The acquisition of Axiall in 2016 made it a North American leader in chlor-alkali and PVC. Today, Westlake has two defined segments: performance and essential materials, and housing and infrastructure products. The HIP segment began operating in 2022 following a series of acquisitions in the building products space. The firm aims to maximize the value of its chemical production by integrating with the HIP segment, realizing the higher margins of finished commercial goods.
公司地址 2801 Post Oak Boulevard, Suite 600, Houston, TX, USA, 77056
電話號碼 +1 713 960-9111
傳真號碼 --
公司網頁 https://www.westlake.com
員工數量 14600
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. L. Benjamin Ederington Executive Vice President, Legal and External Affairs -- 26/02/2026
Mr. Jonathan H. Baksht Senior Vice President and Chief Financial Officer of the Company and Westlake Chemical Partners GP LLC -- 20/04/2026
Mr. Scott Szwejbka Senior Vice President, Housing & Infrastructure Products Segment Head -- 26/02/2026
Mr. John T. Chao Director; Senior Vice President and Managing Director of Westlake Innovations, Inc. -- 02/04/2026
Mr. Thomas J. Janssens Senior Vice President, Operations - Performance and Essential Material and Corporate Logistics -- 25/02/2025
Mr. Jean-Marc Gilson Director; President and Chief Executive Officer of Company and Westlake Chemical Partners GP LLC 美元 1.29M 23/02/2026
Mr. Jeffrey A. Holy Vice President and Chief Accounting Officer -- 26/02/2026
Mr. Brian Powers Senior Vice President, Performance and Essential Materials Segment Head -- 02/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Albert Y. Chao Executive Chairman of the Board 02/04/2026
Mr. James Y. Chao Senior Chairman of the Board 02/04/2026
Mr. Jeffrey W. Sheets Independent Director 02/04/2026
Ms. Kimberly S. Lubel Independent Director 02/04/2026
Mr. Michael J. Graff Independent Director 02/04/2026
Mr. R. Bruce Northcutt Independent Director 02/04/2026
Mr. Roger A. Cregg Independent Director 02/04/2026
Mr. Mark A. Mccollum Independent Director 02/04/2026
Mr. Bhavesh V. Patel Director 23/02/2026
Mr. David T. Chao Director 02/04/2026
Mr. John T. Chao Director; Senior Vice President and Managing Director of Westlake Innovations, Inc. 02/04/2026
Mr. Jean-Marc Gilson Director; President and Chief Executive Officer of Company and Westlake Chemical Partners GP LLC 23/02/2026
Ms. Carolyn C. Sabat Director 02/04/2026
Ms. Catherine T. Chao Director 02/04/2026
 
所屬ETF (更新日期: 25/07/2026 03:45)
代號 名稱 佔比% 持有日期
CVSMCresAlta Small and Mid-Cap ETF0.02%30/06/2026
EQALInvesco Russell 1000 Equal Weight ETF0.02%30/06/2026
SCHBSchwab US Broad Market ETF™0.02%30/06/2026
VONVVanguard Russell 1000 Value ETF0.02%30/06/2026
PRFInvesco RAFI US 1000 ETF0.01%30/06/2026
SCHVSchwab US Large-Cap Value ETF™0.01%30/06/2026
DFAUDimensional US Core Equity Market ETF0.01%30/06/2026
AVUSAvantis US Equity ETF0.01%30/06/2026
PYZInvesco DW Basic Materials Momt ETF0.01%30/06/2026
BBMCJPMorgan BetaBuilders US Mid Cap Eq ETF0.01%30/06/2026
FMATFidelity MSCI Materials ETF0.01%30/06/2026
DFUSDimensional US Equity Market ETF0.01%30/06/2026
IWViShares Russell 3000 ETF0.01%30/06/2026
ISCGiShares Morningstar Small-Cap Growth ETF0.01%30/06/2026
PTLInspire 500 ETF0.01%29/06/2026
ESGVVanguard ESG US Stock ETF0.01%30/06/2026
SPTMState StreetSPDRPortS&P1500CompStkMktETF0.01%30/06/2026
VONEVanguard Russell 1000 ETF0.004%30/06/2026
BKMCBNY Mellon US Mid Cap Core Equity ETF0.004%30/06/2026
DXUVDimensional US Vector Equity ETF0.004%30/06/2026
  1    2   3    4    5    6    7    8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.